Pfizer Dodges Suit Over Retirement Fund Stock Plummet

Law360, New York (April 1, 2013, 6:54 PM EDT) -- Pfizer Inc. does not owe damages to employees whose company-managed retirement funds lost value when news emerged of possible dangerous side effects in drugs Bextra and Celebrex, a federal judge ruled Friday, dismissing a putative class action against the pharmaceutical giant.

Case law provides a broad protection to companies that buy their own stock with retirement fund money, U.S. District Judge Laura Taylor Swain said in a written opinion, dismissing a case brought by workers who participated in Pfizer retirement funds after their shares plummeted in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In re Pfizer ERISA Litigation


Case Number

1:04-cv-10071

Court

New York Southern

Nature of Suit

Labor: E.R.I.S.A.

Judge

Laura Taylor Swain

Date Filed

December 20, 2004

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.